Alibi Idiris won’t be eligible to return to action until
February. | Getty/UFC
Alibi
Idiris has been suspended for one year after failing a drug
test in relation to his most recent Octagon appearance.
The
UFC flyweight tested positive for hydrochlorothiazide in an
in-competition sample collected on Feb. 21 in Houston, Combat
Sports Anti-Doping (CSAD) announced on Tuesday. Idiris defeated Ode
Osbourne in a 125-pound matchup at
UFC Houston — also known as UFC Fight Night 267 — on that
date.
As a result, Idiris has been suspended for one year, and he will be
eligible to return on on Feb. 21, 2027. According to CSAD, Idiris
revealed that he had taken hydrochlorothiazide on Thursday of UFC
Houston fight week to help with his weight cut.
No Reduction
“Although Idiris has been fully cooperative with CSAD, CSAD is not
suspending or reducing any period of his ineligibility due to the
seriousness of knowingly using a diuretic during fight week and the
advantage that he received in making his contracted weight,” the
anti-doping agency stated.
Additionally, Idiris’ victory was overturned to a no contest by the
Texas Department of Licensing and Regulation.
A 31-year-old native of Aktau, Kazakhstan, Idiris was victorious in
his first 10 professional appearances. He made it to the finals of
“The Ultimate Fighter 33” before losing to Joseph
Morales in his Octagon debut — which also doubled as the
reality show finale — at UFC 319.